Explore a comprehensive review of clinical studies on Pelvic Congestion Syndrome (PCS) treatments, including medical, endovascular, and surgical approaches. Understand the efficacy, outcomes, and future directions in managing chronic pelvic pain caused by venous insufficiency.

Clinical Studies on Pelvic Congestion Syndrome Treatments: A Review

I. Introduction

Pelvic Congestion Syndrome (PCS) is a chronic condition characterized by persistent pelvic pain, often exacerbated by prolonged standing, intercourse, or during menstruation. It is primarily caused by venous insufficiency in the pelvic region, leading to dilated and incompetent veins, similar to varicose veins in the legs [1]. PCS significantly impacts the quality of life for many women, often leading to misdiagnosis and delayed treatment due to its varied presentation and overlap with other pelvic pain conditions. The evaluation of treatment efficacy for PCS relies heavily on robust clinical studies that provide evidence-based insights into various therapeutic approaches. This review aims to synthesize findings from key clinical studies on PCS treatments, offering a comprehensive overview for both patients and healthcare professionals.

**Disclaimer:** This article is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare professional for diagnosis and treatment of any medical condition.

II. Understanding Pelvic Congestion Syndrome

Pathophysiology

PCS is fundamentally a vascular disorder, stemming from **pelvic venous insufficiency** where valves in the ovarian and internal iliac veins become incompetent, leading to retrograde blood flow and venous dilation [2]. This engorgement of pelvic veins results in chronic pain and other associated symptoms. The anatomical complexity of the pelvic venous system contributes to the challenge of diagnosis and treatment.

Symptoms

The hallmark symptom of PCS is chronic pelvic pain lasting more than six months, often described as a dull ache that worsens throughout the day, particularly with prolonged standing. Other common symptoms include dyspareunia (painful intercourse), dysmenorrhea (painful menstruation), post-coital pain, and a feeling of heaviness in the pelvis [3]. The variability of these symptoms often complicates diagnosis.

Diagnosis

Accurate diagnosis of PCS is crucial for effective treatment. Diagnostic modalities include transvaginal ultrasound, computed tomography (CT), magnetic resonance imaging (MRI), and venography. **Pelvic venography** is considered the gold standard, providing detailed visualization of the venous anatomy and confirming venous reflux [4]. MRI and CT scans can also identify dilated pelvic veins and rule out other causes of pelvic pain.

III. Treatment Modalities for PCS

Treatment for PCS ranges from conservative medical management to minimally invasive endovascular procedures and, in select cases, surgical interventions. Clinical studies have explored the efficacy and safety of these diverse approaches.

A. Medical Management

Medical therapies primarily focus on symptom management and hormonal modulation. Hormonal treatments, such as **medroxyprogesterone acetate** and **GnRH agonists**, aim to suppress ovarian function and reduce venous congestion [3]. While some studies suggest symptomatic relief in a subset of patients, the long-term efficacy and side effect profiles often limit their widespread use as a definitive treatment [16]. Pain management strategies, including NSAIDs and analgesics, provide symptomatic relief but do not address the underlying venous pathology.

B. Endovascular Treatments (Minimally Invasive)

**Pelvic Vein Embolization (PVE)** has emerged as a highly effective and widely adopted minimally invasive treatment for PCS. This procedure involves occluding the incompetent pelvic veins using various embolic agents to redirect blood flow away from the congested areas. Common techniques include:

**Coil Embolization:** Placement of metallic coils within the incompetent veins to induce thrombosis and occlusion [5].
**Sclerotherapy:** Injection of a sclerosant agent (e.g., foam or liquid) into the veins to cause irritation and closure [9].
**Plug Embolization:** Use of vascular plugs to mechanically occlude the veins [9].

Clinical studies consistently report high technical success rates for PVE, often ranging from 98-100% [10]. Symptom improvement rates are also significant, with many studies showing 80-90% of patients experiencing moderate to significant relief from chronic pelvic pain and other symptoms within 1-3 months post-procedure [11] [13]. A systematic review by Brown et al. (2018) highlighted clinical improvement in 83-96% of patients across various studies [1]. Recurrence rates after PVE are generally low, reported to be around 5% in some cohorts [12].

Ongoing research, such as the **EMBOLIZE Trial**, aims to further evaluate the efficacy of minimally invasive treatments in relieving chronic pelvic pain and improving quality of life for women with pelvic venous disorders through randomized controlled trials [8]. This trial seeks to provide higher-level evidence to support current practices.

C. Surgical Interventions

Surgical options for PCS are typically reserved for cases where medical and endovascular treatments have failed or are contraindicated. Historically, **ligation of ovarian veins** was performed, but its role has diminished with the advent of less invasive techniques. In severe, refractory cases, **hysterectomy and oophorectomy** may be considered, particularly if there are co-existing gynecological pathologies [19]. However, these are major surgical procedures with associated risks and are not considered first-line treatments for PCS alone.

IV. Efficacy and Outcomes from Clinical Studies

Numerous clinical studies, including systematic reviews and meta-analyses, have underscored the effectiveness of PVE in treating PCS. These studies frequently report significant improvements in patient-reported outcomes, including reduction in pain scores, improved quality of life, and decreased reliance on pain medication [4] [6].

Despite the promising results, challenges in PCS research persist. The heterogeneity of study designs, lack of large-scale randomized controlled trials (RCTs), and varied diagnostic criteria can make direct comparisons difficult [14] [15]. Many studies are retrospective or observational, highlighting the need for more rigorous prospective research.

V. Future Directions and Research Gaps

The future of PCS treatment research lies in addressing current gaps. There is a clear need for more **randomized controlled trials** to establish definitive comparative efficacy between different treatment modalities, particularly between medical and endovascular approaches [17]. Standardization of diagnostic criteria and outcome measures will also enhance the comparability and generalizability of research findings. Furthermore, exploring emerging therapies and technologies, as well as long-term follow-up studies, will be crucial for optimizing patient care.

VI. Conclusion

Pelvic Congestion Syndrome is a significant cause of chronic pelvic pain, and its effective management relies on a thorough understanding of its pathophysiology and available treatments. Clinical studies have demonstrated that **pelvic vein embolization** is a safe and highly effective minimally invasive treatment, offering substantial symptom relief and improved quality of life for many patients. While medical management provides symptomatic relief, it often does not address the underlying cause. Surgical interventions are typically reserved for complex or refractory cases. An individualized treatment approach, guided by evidence from clinical studies and patient-specific factors, is paramount. Continued research, particularly through well-designed randomized controlled trials, is essential to further refine diagnostic and therapeutic strategies for PCS.

VII. Disclaimer

This article is intended for informational purposes only and should not be considered medical advice. It is crucial to consult with a qualified healthcare professional for any health concerns, diagnosis, or treatment decisions related to Pelvic Congestion Syndrome or any other medical condition. The information provided herein is not a substitute for professional medical judgment.

VIII. References

[1] Brown, C. L., et al. (2018). Pelvic Congestion Syndrome: Systematic Review of Treatment.... *PMC, NCBI*. [https://pmc.ncbi.nlm.nih.gov/articles/PMC5886772/]
[2] Kavallieros, K., et al. (2024). Identification of outcomes in clinical studies for pelvic.... *ScienceDirect*. [https://www.sciencedirect.com/science/article/pii/S2213333X24001562]
[3] Kuo, C. H., et al. (2025). Pelvic Congestion Syndrome - StatPearls - NCBI Bookshelf. *NCBI Bookshelf*. [https://www.ncbi.nlm.nih.gov/books/NBK560790/]
[4] Senechal, Q., et al. (2021). Endovascular Treatment of Pelvic Congestion Syndrome. *Frontiers in Cardiovascular Medicine*. [https://www.frontiersin.org/journals/cardiovascular-medicine/articles/10.3389/fcvm.2021.751178/full]
[5] Rizer, M., et al. (2015). Pelvic congestion syndrome: review of treatment success. *JVIR*. [https://www.jvir.org/article/S1051-0443(14)01822-3/fulltext]
[6] de Carvalho, S. F. C., et al. (2023). Pelvic venous reflux embolization in the treatment.... *Journal of Vascular Surgery: Venous and Lymphatic Disorders*. [https://www.jvsvenous.org/article/S2213-333X(22)00436-X/fulltext]
[7] Peraza-Arjona, M. A., et al. (2025). Selective Embolization in the Treatment of Pelvic Congestion.... *PMC, NCBI*. [https://pmc.ncbi.nlm.nih.gov/articles/PMC11926658/]
[8] EMBOLIZE Trial. (2024). *Weill Cornell Medicine News*. [https://news.weill.cornell.edu/news/2024/12/embolize-trial-aims-to-ease-pain-for-women-with-pelvic-venous-disorders]
[9] Effectiveness of Endovascular Plug Embolization in Pelvic.... (2026). *TrialX*. [https://www.trialx.com/clinical-trials/listings/304280/effectiveness-of-endovascular-plug/]
[10] Efficacy of embolotherapy for the treatment of pelvic congestion.... *PMC, NCBI*. [https://pmc.ncbi.nlm.nih.gov/articles/PMC11128397/]
[11] Efficacy of endovascular treatment for pelvic congestion syndrome. *ScienceDirect*. [https://www.sciencedirect.com/science/article/pii/S2213333X16000068]
[12] Effectiveness of treatment for pelvic congestion syndrome. *Phlebolymphology*. [https://www.phlebolymphology.org/effectiveness-treatment-pelvic-congestion-syndrome/]
[13] Efficacy of endovascular treatment for pelvic congestion syndrome. *PubMed*. [https://pubmed.ncbi.nlm.nih.gov/27318059/]
[14] Borghi, C., Dell\'Atti, L. (2016). Pelvic congestion syndrome: the current state of the literature. *Archives of Gynecology and Obstetrics*. [https://link.springer.com/article/10.1007/s00404-015-3895-7]
[15] Brown, C. L., et al. (2018). Pelvic congestion syndrome: systematic review of treatment success. *Seminars in Interventional Radiology*. [https://www.thieme-connect.com/products/all/doi/10.1055/s-0038-1636519]
[16] Tu, F. F., et al. (2010). Pelvic congestion syndrome-associated pelvic pain: a systematic review of diagnosis and management. *Obstetrical & Gynecological Survey*. [https://journals.lww.com/obgynsurvey/fulltext/2010/05000/Chronic_Pelvic_Pain.00022.aspx]
[17] Smith, P. C. (2012). The outcome of treatment for pelvic congestion syndrome. *Phlebology*. [https://journals.sagepub.com/doi/abs/10.1258/phleb.2011.012s01]
[18] Schuler, C., et al. (2021). What is the best therapy for PCS?. *Evidence-Based Practice*. [https://journals.lww.com/ebp/fulltext/2021/10000/What_is_the_best_therapy_for_PCS_.29.aspx]
[19] O\'Brien, M. T., Gillespie, D. L. (2015). Diagnosis and treatment of the pelvic congestion syndrome. *Journal of Vascular Surgery: Venous and Lymphatic Disorders*. [https://www.sciencedirect.com/science/article/pii/S2213333X1400095X]
[20] Gavrilov, S. G., Turischeva, O. O. (2017). Conservative treatment of pelvic congestion syndrome: indications and opportunities. *Current Medical Research and Opinion*. [https://www.tandfonline.com/doi/full/10.1080/03007995.2017.1302414]

Clinical Studies on Pelvic Congestion Syndrome Treatments: A Review